|Anti-β-Gal-hIgG4 (S228P)||Unit size||Cat. code||Docs||Qty||Price|
Isotype control - Human IgG4 (S228P)
Monoclonal human IgG4 (S228P) antibody against E. coli β-galactosidase
Anti-β-Gal-hIgG4 (S228P) features the constant region of the human IgG4 (S228P) isotype and the variable region of Mouse IgG2a Control. Mouse IgG2a Control is a mouse IgG2a monoclonal antibody that targets E. coli β-galactosidase (β-Gal).
This antibody was generated by DNA immunization with a plasmid expressing the β-Gal gene in Swiss mice. Anti-β-Gal-hIgG4 (S228P) can be used as an isotype control for human IgG4 (S228P) antibodies. It contains an engineered hinge region mutation (S228P) designed to prevent exchange of IgG4 molecules.
Anti-β-Gal-hIgG4 (S228P) was generated by recombinant DNA technology. It has been produced in CHO cells and purified by affinity chromatography.
Clonality: Monoclonal antibody
Specificity: Targets cells expressing E. coli β-galactosidase (β-Gal)
Isotype: Human IgG4 (S228P)
Application: Negative control for human IgG4 (S228P) antibodies
- The absence of binding of Anti-β-Gal-hIgG4 (S228P) to human cell lines has been controlled using flow cytometry.
- The absence of endotoxins and other bacterial contaminants has been confirmed using HEK-Blue™ TLR4 and HEK-Blue™ TLR2 cells.
200 µg purified anti-β-Gal-IgG4 (S228P) antibody, provided azide-free and lyophilizedBack to the top